Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006076

President and CEO acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2014-02-06 Grant or award : show line 1 in the form +210,000 244,173 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-02-06 Grant or award : show line 2 in the form Stock Options +60,000 786,466 D
Loading xslF345X03/rrd402056.xml…